BioSig Announces Closing of Public Offering of Common Stock
23 mars 2022 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, March 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Technologies, Inc. Announces $3 Million Financing with Family Office
22 mars 2022 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, March 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Technologies, Inc. Appoints John Sieckhaus as Chief Operating Officer
16 mars 2022 09h00 HE
|
BioSig Technologies, Inc.
Westport, CT, March 16, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Awarded US Patent Claims for its PURE EP™ Noise-Filtering Technology
26 janv. 2022 13h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Claims address computer-implemented systems and methods for filtering noise from input cardiac signals using its PURE EP™ technologyThe Company now...
BioSig to Present at the 27th Annual International AF Symposium
07 janv. 2022 10h20 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig to Present at the 24th Annual Virtual Needham Growth Conference
06 janv. 2022 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 06, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales
21 déc. 2021 09h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Expands Its Clinical Footprint In Florida
16 déc. 2021 09h15 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 16, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Global Electrophysiology Devices Market Report 2021: Strategic Imperatives for EP Device Makers in a Rapidly Evolving Ecosystem
14 déc. 2021 10h38 HE
|
Research and Markets
Dublin, Dec. 14, 2021 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Global Electrophysiology Devices" report has been added to ResearchAndMarkets.com's offering. The electrophysiology (EP)...
BioSig to Host Conference Call on December 21, 2021
13 déc. 2021 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...